Summary of the key World Health Organization's recommendations on the minimum criteria national programmes needed to safely and effectively use new drugs
| Bedaquiline | Requirements for countries | Delamanid |
| 400 mg per day for 2 weeks then 200 mg three times a week for 22 weeks Pharmacovigilance Informed consent QT monitoring | Country preparedness and planning National plan new tools Monitoring and evaluation (drug-resistance surveillance and pharmacovigilance) Private sector engaged Uninterrupted supply Operational research | 100 mg two times a day for 6 or 12 months added to OBR in adults Pharmacovigilance Informed consent Not added to bedaquiline |
Data taken from [4] for bedaquiline, [5] for requirements for countries, and [6] for delamanid. QT: interval measure of the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle.